TipRanks
Go Ultimate55% OFF

Timothy Walbert Insider Profile

11 Followers

Timothy Walbert, Director at Kardigan, Inc., holds 20.71K shares in Kardigan, Inc. (Ticker: KARD), holds 17.69K shares in BioMarin Pharmaceutical (Ticker: BMRN), holds 211.11K shares in Assertio Therapeutics (Ticker: ASRT).

Timothy Walbert's Trading History

KARD
Kardigan, Inc.
Jun 22, 2026DirectorUninformative Buy―$292.58K
BMRN
BioMarin Pharmaceutical
Jun 04, 2026DirectorUninformative Buy―$1.03M
MIRM
Mirum Pharmaceuticals
Jun 02, 2026DirectorUninformative Buy403.67K$822.80K
HZNP
Horizon Therapeutics
Oct 06, 2023―Uninformative Sell101.91M$109.88M
ASRT
Assertio Therapeutics
May 22, 2020―Uninformative Buy―$4.96M
ZCOR
Zyla Life Sciences
May 21, 2020―Uninformative Sell―$0.00
EGLTQ
Egalet Corp
Feb 04, 2019―Uninformative Sell―$0.00
SCMP
Sucampo Pharmaceuticals
Feb 13, 2018―Uninformative Sell92.34K$0.00
XOMA
XOMA Royalty Corporation
Aug 02, 2016―Uninformative Buy―$3.26M
RPTP
Raptor Pharmaceutical Corp.
Mar 17, 2014―Uninformative Sell83.97K$0.00
INSYQ
Insys Therapeutics
―――$42.00
ODTX
Odyssey Therapeutics, Inc.
―Director――
SGMT
Sagimet Biosciences, Inc. Class A
―Director――
IPSC
Century Therapeutics
―Director――
XCUR
Exicure
―Director――
AUPH
Aurinia Pharmaceuticals
―Director――

You May Also Like

Timothy Walbert insider profile FAQ

What stocks does Timothy Walbert hold?
Timothy Walbert holds: KARD, BMRN, ASRT, XOMA, AUPH, MIRM, XCUR, ZCOR, IPSC, SGMT, ODTX, SCMP, INSYQ, HZNP, RPTP, EGLTQ stocks.
What is Timothy Walbert's role in Kardigan, Inc.?
Timothy Walbert's role in Kardigan, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.